Somatic Mutations in Progeria Vascular Damage

Close up of blood vessels.
Image Credit: Scientific Frontline / stock image

Scientific Frontline: Extended "At a Glance" Summary: Vascular Damage in Progeria

The Core Concept: Hutchinson–Gilford progeria syndrome (HGPS) is a rare genetic disorder characterized by remarkable premature aging, where fatal cardiovascular deterioration is driven by the progressive accumulation of somatic mutations within the vascular wall.

Key Distinction/Mechanism: While HGPS originates from a primary inherited genetic mutation, the subsequent vascular collapse is caused by a secondary, progressive accumulation of somatic (acquired) mutations over the patient's lifetime. This high mutation burden triggers severe cellular stress, activates DNA damage response genes, strips cells of their identity, and ultimately kills the smooth muscle cells that provide blood vessels with structural strength and elasticity.

Major Frameworks/Components:

• Single-Cell RNA Sequencing (scRNA-seq): An advanced genomic technique used to analyze gene activity in nearly 9,000 individual cells, enabling a step-by-step observation of disease progression.
• Somatic Mutation Accumulation: The lifetime buildup of non-inherited genetic alterations, now identified as a primary hallmark of vascular disease in HGPS.
• Vascular Smooth Muscle Cell (VSMC) Degradation: The critical, progressive loss of the specific cells required to maintain vessel integrity, leaving the vascular wall weak and susceptible to disease.
• Intercellular Signaling: Evidence suggesting that structural deterioration is compounded by aberrant communication between different cell types within the vessel wall, rather than isolated individual cellular defects.

Branch of Science: Molecular Biology, Genetics, Cellular Biology, and Cardiology.

Future Application: These findings highlight the critical need for early-intervention gene-editing therapies, as correcting the root HGPS mutation will not reverse the damage in cells that have already accumulated a high somatic mutation burden. Furthermore, because HGPS closely mirrors natural vascular aging, these cellular models offer critical pathways for developing treatments targeting age-related cardiovascular disease in the general population.

Why It Matters: The vast majority of HGPS patients die from cardiovascular disease during their teenage years. Identifying accumulated somatic mutations as the irreversible driver of this vascular failure fundamentally shifts the clinical focus toward intervening before permanent DNA damage accrues in the vascular wall.

Maria Eriksson
Photo Credit: Stefan Zimmerman

In the rare disease progeria, blood vessels deteriorate prematurely. A study from Karolinska Institutet shows how different cell types in the vascular wall undergo progressive changes and accumulate mutations over time. The findings are published in the journal Genome Medicine.

Hutchinson–Gilford progeria syndrome (HGPS) is a genetic disorder that causes remarkable premature aging. Most patients die during their teenage years from cardiovascular disease, but the precise mechanisms underlying vascular damage remain unclear.

In the new study, researchers analyzed cells from the aorta of mice carrying the same genetic mutation found in people with progeria. Using single-cell RNA sequencing, which enables gene activity to be studied in individual cells, they tracked how the vascular wall changes over time. In total, nearly 9,000 cells from mice of different ages were analyzed.

“This approach allows us to follow, step by step, how different cell types are affected throughout the course of the disease,” says Maria Eriksson, professor at the Department of Medicine, Huddinge, Karolinska Institutet.

Lara Garcia Merino
Photo Credit: Fabiana Stefani

Reduced Numbers of Smooth Muscle Cells

The researchers focused particularly on vascular smooth muscle cells, which provide blood vessels with strength and elasticity and are essential for normal vascular function. They observed that these cells gradually declined in number.

“Smooth muscle cells are progressively lost both in HGPS and during normal aging. As these cells die, the vessel wall becomes weaker and more susceptible to disease,” says Lara Garcia Merino, a doctoral student at the same department and first author of the study.

The study also showed that smooth muscle cells accumulated higher numbers of so-called somatic mutations, meaning genetic alterations that arise during an individual’s lifetime. The mutation burden was associated with increased cellular stress and the activation of genes involved in DNA damage responses.

“This is the first evidence that the accumulation of somatic mutations is a hallmark of vascular disease in HGPS,” says Maria Eriksson.

Reveals a New Mechanism

The findings link DNA damage to cellular stress, loss of cellular identity, and cell death, thereby revealing a previously unrecognized mechanism driving irreversible vascular injury.

The researchers also found evidence that changes in cell behavior may be influenced by signaling between different cell types within the vessel wall, suggesting that the process is not driven solely by alterations within individual cells.

“We see that cells undergo multiple changes over time, from stress to identity changes, and ultimately cell death. Our results suggest that several different mechanisms interact in the development of vascular damage in progeria,” says Lara Garcia Merino.

The researchers believe that the findings may contribute to a better understanding of how vascular damage develops in progeria and underline the importance of initiating treatment early, before irreversible DNA damage has accumulated.

“New gene-editing approaches can correct the disease-causing mutation in HGPS, but correcting the mutation alone is unlikely to reverse damage in cells that have already accumulated a large number of somatic mutations. Early intervention is therefore essential,” says Maria Eriksson.

The study also provides new insights into the biological processes underlying normal vascular aging. Several important similarities exist between HGPS and the cardiovascular disease that affects the general population. HGPS is therefore widely used as a model for understanding normal aging and vascular disease.

The researchers emphasize that further studies are needed to confirm the findings in humans.

Additional information: The study was conducted in collaboration with researchers from, among others, the Indian Institute of Technology in India and the University of Bergen in Norway. 

Funding: The research was funded by the Swedish Research Council, the European Research Council (ERC), the Swedish Cancer Society, and the Center for Innovative Medicine, among others.

Published in journal: Genome Medicine

Title: Single-cell analysis of the progeria arterial wall reveals progerin-induced progressive, cell type-specific dysfunction and somatic mutation accumulation

Authors: Lara G. Merino, Gwladys Revêchon, Santhilal Subhash, Fabiana Stefani, Daniel Whisenant, Marianna Skipitari, Quentin Giraud, Lars Muhl, Giuseppe Mocci, Johan Björkegren, Piotr Machtel, Liqun He, Christer Betsholtz, and Maria Eriksson

Source/Credit: Karolinska Institutet

Edited by: Scientific Frontline

Reference Number: mbio073126_01

Privacy Policy | Terms of Service | Contact Us